Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Laurus Labs Limited
LAURUSLABSLaurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
Analytics
WallStreetin tavoitehinta
47 253.13 INRP/E-suhde
203.8163Osinkotuotto
0.17 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut LAURUSLABS
Osinkoanalytiikka LAURUSLABS
Osinkojen kasvu 5 vuoden aikana
433 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
37 %Osinkohistoria LAURUSLABS
Osakkeen arvostus LAURUSLABS
Talousasiat LAURUSLABS
Tuloksia | 2019 | Dynamiikka |